Dicks Sporting Goods Inc vs Pfizer Inc — how do they compare? Dicks Sporting Goods Inc trades at $205.76 (market cap $18.35B), while Pfizer Inc trades at $26.51 (market cap $151.73B). The key difference: Pfizer Inc is far larger — about 8.3× Dicks Sporting Goods Inc's market cap, and Pfizer Inc pays the higher dividend (6.46%). Which is the better fit depends on your goals.
| DKS | PFE | |
|---|---|---|
Market Cap | $18.35B | $151.73B |
Sector | Consumer Cyclical | Health |
52-Week High | $239.17 | $28.56 |
52-Week Low | $187.78 | $23.60 |
Enterprise Value | $25.14B | $203.22B |
Dividend Yield | 2.44% | 6.46% |
Volume | — | 29,869,932 |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Pfizer (PFE) trades at $27.05, up 1.16% with a bullish technical signal and consistent earnings beats in recent quarters. Revenue remains stable around $62-63 billion, though net income is projected to decline in 2026. The stock shows strong profitability margins and a solid balance sheet, but faces headwinds from patent expirations and competitive pressures.
The outlook is mixed: valuation multiples appear reasonable, and analyst consensus leans hold with a $27.86 target. Key risks include execution on pipeline catalysts and margin compression. Upside depends on successful drug launches and cost management amid a challenging revenue environment.
Trailing returns across standard periods
Latest headlines on both assets
Dick's Sporting Goods is a leading omni-channel sporting goods retailer in the US It offers an extensive assortment of authentic sports equipment, apparel, footwear, and accessories through its stores and digital platforms.
Read more on DKS →Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →